pI: 6.6094 |
Length (AA): 784 |
MW (Da): 87084 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128455)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G17410 | Spc97 / Spc98 family of spindle pole body (SBP) component |
Babesia bovis | BBOV_II001290 | spc97 / spc98 family protein |
Brugia malayi | Bm1_24520 | Spc97 / Spc98 family protein |
Candida albicans | CaO19.708 | similar to S. cerevisiae SPC97 (YHR172W) spindle pole body component |
Candida albicans | CaO19.8327 | similar to S. cerevisiae SPC97 (YHR172W) spindle pole body component |
Cryptosporidium hominis | Chro.70344 | PV1H14095_P-related |
Cryptosporidium parvum | cgd7_3060 | gamma-tubulin complex associated protein |
Dictyostelium discoideum | DDB_G0285849 | spindle pole body component 97 |
Drosophila melanogaster | Dmel_CG3917 | Gamma-tubulin ring protein 84 |
Echinococcus granulosus | EgrG_000621500 | gamma tubulin complex component 2 |
Entamoeba histolytica | EHI_043950 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000621500 | gamma tubulin complex component 2 |
Giardia lamblia | GL50803_17429 | Tubulin, small gamma tubulin complex gcp2 |
Homo sapiens | ENSG00000130640 | tubulin, gamma complex associated protein 2 |
Leishmania braziliensis | LbrM.35.4630 | gamma-tubulin complex subunit, putative |
Leishmania donovani | LdBPK_364610.1 | gamma-tubulin complex component 2 |
Leishmania infantum | LinJ.36.4610 | gamma-tubulin complex subunit, putative |
Leishmania major | LmjF.36.4390 | gamma-tubulin complex subunit, putative |
Leishmania mexicana | LmxM.36.4390 | gamma-tubulin complex subunit, putative |
Loa Loa (eye worm) | LOAG_06718 | hypothetical protein |
Mus musculus | ENSMUSG00000025474 | tubulin, gamma complex associated protein 2 |
Neospora caninum | NCLIV_024430 | gamma-tubulin complex component 2, putative |
Oryza sativa | 4336312 | Os04g0501700 |
Onchocerca volvulus | OVOC12221 |
|
Saccharomyces cerevisiae | YHR172W | Spc97p |
Schistosoma japonicum | Sjp_0069270 | Gamma-tubulin complex component 2, putative |
Schistosoma japonicum | Sjp_0212770 | ko:K06540 a disintegrin and metalloproteinase domain 8, putative |
Schistosoma mansoni | Smp_125530 | gamma-tubulin complex component 2 (gcp-2) |
Schmidtea mediterranea | mk4.002585.02 | Gamma-tubulin complex component 2 |
Schmidtea mediterranea | mk4.002585.03 | Gamma-tubulin complex component 2 |
Trypanosoma brucei gambiense | Tbg972.10.11940 | gamma-tubulin complex subunit, putative,spindle pole body protein, putative |
Trypanosoma brucei | Tb927.10.9770 | gamma-tubulin complex component 2 |
Trypanosoma brucei | Tb11.v5.0848 | gamma-tubulin complex subunit, putative |
Trypanosoma congolense | TcIL3000_10_8580 | gamma-tubulin complex component 2 |
Trypanosoma cruzi | TcCLB.504147.170 | gamma-tubulin complex component 2 |
Toxoplasma gondii | TGME49_263510 | Spc97 / Spc98 family protein |
Trichomonas vaginalis | TVAG_081520 | gamma tubulin complex protein, putative |
Trichomonas vaginalis | TVAG_206250 | gamma tubulin complex protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9770 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9770 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9770 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.9770 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YHR172W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_263510 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.